• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Phathom

Seriously did everyone get the letter? I accepted a job before Christmas. And then this email shows up today. Why didn’t they have the managers at least call their reps????? After all the interviewing?? My manager was on a call at 4:30 pm w Phathom management l. Anyone heard anything else?
 








We wanted to reach out as soon as possible to alert you that today we announced that the FDA will not be approving Phathom’s NDA for vonoprazan for treatment of erosive esophagitis (EE) on the January 11, 2023, PDUFA target action date as we originally expected. Based on this recent development, we no longer be launching vonoprazan for treatment EE or H. pylori infection in the first quarter of 2023. Regrettably, this development means that we will not be extending you a formal offer to join Phathom as a sales representative at this time.



We sincerely appreciate your interest and willingness to join Phathom and share your disappointment. We wish you all the best in your future endeavors and will remain in touch as we work with FDA to bring our products to patients.
 
















































Haven’t heard from my manager yet. I called HR rep and she confirmed what was in the email.
What’s there to hear from any manager in this company they has NO DRUGS TO SELL??? ‍♀️. You don’t have an offer, you don’t have a manger, and you don’t have a job in this ridiculously useless company that jerked ppl around for months. Thanks god I didn’t wait for them and got a job, even though i accepted their offer and my to-be manger called every month telling how they can’t wait to work with me. ‍♀️♀️♀️♀️.
 








Obviously I can’t wait around for this and thankfully I’m still employed, but I think it will eventually resolve. The FDA already negotiated negligible amount threshold which manufacturer met. Now they just want to see how it maintains during shelf life. I think it would have been a great med to promote and the GI docs I call on were super excited. I really don’t think they’ll sell but maybe I’m wrong.
 




So for those that received offers… have you heard from your respective managers? Any feedback you can share?
It’s definitely not over IMO. My manager reached out yesterday before I saw the email and said that its delayed bc the
FDA said they have to show shelf life and that they are currently developing launch scenarios, but it sounds like it won’t be until after Q1.
Based on the letter from HR I also felt like they were resending the offer all together, so I asked the hiring manager if I would have to re-interview, hen the drug was approved and she said that that wouldn’t be necessary.
 








Guess what? How do you document shelf life of over a year? You have to wait at least a year - there’s no rushing a shelf life study requirement … #Phucked

they want to see the already declared “negligible levels” decline over time. It’s been since august and those pills were made moths prior. Just saying.